Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

JUAN I LOMBEIDA

Allopathic & Osteopathic Physicians Internal Medicine Hospice and Palliative Medicine

NPI
1043434202
CMS profile
934025
Location
FAYETTEVILLE, AR

General Payments · PY2018–2024

$2,820.72

  • Reported across 201 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$551.93

35 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $551.93 35

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $225.48 17
PY2019 $520.79 37
PY2020 $486.08 34
PY2021 $401.75 33
PY2022 $327.42 24
PY2023 $307.27 21
PY2024 $551.93 35

Payment records · PY2024 (35)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ADC Therapeutics America, Inc. $13.07 08/12/2024 Food and Beverage Undisputed 01/23/2026 1121192005 CMS
AstraZeneca Pharmaceuticals LP $13.54 03/13/2024 Food and Beverage Undisputed 01/23/2026 1104306680 CMS
AstraZeneca Pharmaceuticals LP $13.38 09/04/2024 Food and Beverage Undisputed 01/23/2026 1105729751 CMS
AstraZeneca Pharmaceuticals LP $13.33 11/11/2024 Food and Beverage Undisputed 01/23/2026 1105628598 CMS
Aveo Pharmaceuticals, Inc. $13.35 08/27/2024 Food and Beverage Undisputed 01/23/2026 1143480331 CMS
Bayer Healthcare Pharmaceuticals Inc. $13.15 01/24/2024 Food and Beverage Undisputed 01/23/2026 1086194868 CMS
Daiichi Sankyo Inc. $15.78 02/23/2024 Food and Beverage Undisputed 01/23/2026 1089449626 CMS
Daiichi Sankyo Inc. $15.19 04/01/2024 Food and Beverage Undisputed 01/23/2026 1089449624 CMS
Daiichi Sankyo Inc. $20.94 05/09/2024 Food and Beverage Undisputed 01/23/2026 1089449628 CMS
Daiichi Sankyo Inc. $18.13 09/16/2024 Food and Beverage Undisputed 01/23/2026 1089449622 CMS
Eisai Inc. $16.88 01/08/2024 Food and Beverage Undisputed 01/23/2026 1110756060 CMS
Eisai Inc. $15.10 10/04/2024 Food and Beverage Undisputed 01/23/2026 1110756058 CMS
Genmab U.S., Inc. $18.21 09/27/2024 Food and Beverage Undisputed 01/23/2026 1126828244 CMS
Incyte Corporation $13.12 03/14/2024 Food and Beverage Undisputed 01/23/2026 1141179722 CMS
Iovance Biotherapeutics, Inc. $14.31 11/04/2024 Food and Beverage Undisputed 01/23/2026 1147113900 CMS
Janssen Biotech, Inc. $21.22 05/17/2024 Food and Beverage Undisputed 01/23/2026 1078267523 CMS
Janssen Biotech, Inc. $18.65 07/09/2024 Food and Beverage Undisputed 01/23/2026 1078267673 CMS
Janssen Biotech, Inc. $20.04 08/28/2024 Food and Beverage Undisputed 01/23/2026 1078267575 CMS
Lilly USA, LLC $30.22 12/18/2024 Food and Beverage Undisputed 01/23/2026 1135075099 CMS
Menarini Silicon Biosystems, Inc. $13.25 10/01/2024 Food and Beverage Undisputed 01/23/2026 1107214581 CMS
Merck Sharp & Dohme LLC $13.49 05/29/2024 Food and Beverage Undisputed 01/23/2026 1141684279 CMS
Merck Sharp & Dohme LLC $16.97 07/01/2024 Food and Beverage Undisputed 01/23/2026 1141684281 CMS
Novartis Pharmaceuticals Corporation $15.04 10/21/2024 Food and Beverage Undisputed 01/23/2026 1087035214 CMS
Novartis Pharmaceuticals Corporation $13.65 10/22/2024 Food and Beverage Undisputed 01/23/2026 1087035216 CMS
PFIZER INC. $13.07 10/12/2024 Food and Beverage Undisputed 01/23/2026 1131373979 CMS
Pharmacosmos Therapeutics Inc. $13.12 07/26/2024 Food and Beverage Undisputed 01/23/2026 1154823655 CMS
Regeneron Healthcare Solutions, Inc. $13.28 02/06/2024 Food and Beverage Undisputed 01/23/2026 1114103043 CMS
Regeneron Healthcare Solutions, Inc. $13.41 04/02/2024 Food and Beverage Undisputed 01/23/2026 1114103045 CMS
Regeneron Healthcare Solutions, Inc. $14.59 04/05/2024 Food and Beverage Undisputed 01/23/2026 1114103047 CMS
Regeneron Healthcare Solutions, Inc. $15.17 06/11/2024 Food and Beverage Undisputed 01/23/2026 1114103049 CMS
Regeneron Healthcare Solutions, Inc. $13.53 07/08/2024 Food and Beverage Undisputed 01/23/2026 1114103051 CMS
Regeneron Healthcare Solutions, Inc. $15.22 08/09/2024 Food and Beverage Undisputed 01/23/2026 1114103053 CMS
Regeneron Healthcare Solutions, Inc. $14.70 09/20/2024 Food and Beverage Undisputed 01/23/2026 1114103055 CMS
Takeda Pharmaceuticals U.S.A., Inc. $21.13 03/25/2024 Food and Beverage Undisputed 01/23/2026 1137622917 CMS
Takeda Pharmaceuticals U.S.A., Inc. $14.70 12/16/2024 Food and Beverage Undisputed 01/23/2026 1144961988 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.